A Mendelian randomization study of the effect of calcium on coronary artery disease, myocardial infarction and their risk factors

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Xu, Lin ^a,b   Lin, Shi Lin ^a   Schooling, C Mary ^a,c  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b SUN YAT SEN UNIVERSITY   (China)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCIUM;

ALLELE; BLOOD; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEART INFARCTION; HUMAN; MALE; MENDELIAN RANDOMIZATION ANALYSIS; METABOLISM; ODDS RATIO; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; BIOMARKERS; CALCIUM; CORONARY ARTERY DISEASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; MALE; MENDELIAN RANDOMIZATION ANALYSIS; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK ASSESSMENT; RISK FACTORS;

EID: 85012866922     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep42691     Document Type: Article

References (51)

1. Tai, V., Leung, W., Grey, A., Reid, I. R. & Bolland, M. J. Calcium intake and bone mineral density: systematic review and metaanalysis. BMJ 351, h4183, doi: 10.1136/bmj.h4183 (2015).
2. Bolland, M. J., Grey, A., Avenell, A., Gamble, G. D. & Reid, I. R. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ 342, d2040, doi: 10.1136/bmj.d2040 (2011).
3. Bolland, M. J. et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 341, c3691, doi: 10.1136/bmj.c3691 (2010).
4. Mao, P. J. et al. Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. International journal of cardiology 169, 106-111, doi: 10.1016/j.ijcard.2013.08.055 (2013).
5. Wang, L., Manson, J. E. & Sesso, H. D. Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials. American journal of cardiovascular drugs: drugs, devices, and other interventions 12, 105-116, doi: 10.2165/11595400-000000000-00000 (2012).
6. Lewis, J. R. et al. The Effects of Calcium Supplementation on Verified Coronary Heart Disease Hospitalization and Death in Postmenopausal Women: A Collaborative Meta-Analysis of Randomized Controlled Trials. Journal of Bone and Mineral Research 30, 165-175, doi: 10.1002/jbmr.2311 (2015).
7. Bolland, M. J. et al. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 336, 262-266, doi: 10.1136/bmj.39440.525752.BE (2008).
8. Ioannidis, J. A. Adverse events in randomized trials: Neglected, restricted, distorted, and silenced. Archives of internal medicine 169, 1737-1739, doi: 10.1001/archinternmed.2009.313 (2009).
9. Reid, I. R., Bristow, S. M. & Bolland, M. J. Cardiovascular complications of calcium supplements. Journal of cellular biochemistry 116, 494-501, doi: 10.1002/jcb.25028 (2015).
10. Larsen, E. R., Mosekilde, L. & Foldspang, A. Vitamin D and Calcium Supplementation Prevents Osteoporotic Fractures in Elderly Community Dwelling Residents: A Pragmatic Population-Based 3-Year Intervention Study. Journal of Bone and Mineral Research 19, 370-378, doi: 10.1359/jbmr.0301240 (2004).
11. Tabesh, M., Azadbakht, L., Faghihimani, E., Tabesh, M. & Esmaillzadeh, A. Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial. Diabetologia 57, 2038-2047, doi: 10.1007/s00125-014-3313-x (2014).
12. Sanchez, M. et al. Oral calcium supplementation reduces intraplatelet free calcium concentration and insulin resistance in essential hypertensive patients. Hypertension 29, 531-536 (1997).
13. Haycock, P. C. et al. Best (but oft-forgotten) practices: the design, analysis, and interpretation of Mendelian randomization studies. Am J Clin Nutr, doi: 10.3945/ajcn.115.118216 (2016).
14. Booth, A. O., Huggins, C. E., Wattanapenpaiboon, N. & Nowson, C. A. Effect of increasing dietary calcium through supplements and dairy food on body weight and body composition: a meta-analysis of randomised controlled trials. The British journal of nutrition 114, 1013-1025, doi: 10.1017/S0007114515001518 (2015).
15. Abargouei, A. S., Janghorbani, M., Salehi-Marzijarani, M. & Esmaillzadeh, A. Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obes (Lond) 36, 1485-1493, doi: 10.1038/ijo.2011.269 (2012).
16. O'Seaghdha, C. M. et al. Common variants in the calcium-sensing receptor gene are associated with total serum calcium levels. Human molecular genetics 19, 4296-4303, doi: 10.1093/hmg/ddq342 (2010).
17. Johnson, A. D. et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938-2939 (2008).
18. Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nature genetics 43, 333-338, doi: 10.1038/ng.784 (2011).
19. Nikpay, M. et al. A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease. Nature genetics 47, 1121-1130, doi: 10.1038/ng.3396 (2015).
20. Morris, A. P. et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nature genetics 44, 981-990, doi: 10.1038/ng.2383 (2012).
21. Mahajan, A. et al. Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nature genetics 46, 234-244 (2014).
22. Global Lipids Genetics, C. et al. Discovery and refinement of loci associated with lipid levels. Nature genetics 45, 1274-1283, doi: 10.1038/ng.2797 (2013).
23. Dupuis, J. et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nature genetics 42, 105-116, doi: 10.1038/ng.520 (2010).
24. Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197-206, doi: 10.1038/ nature14177 (2015).
25. Burgess, S., Dudbridge, F. & Thompson, S. G. Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods. Stat Med 35, 1880-1906, doi: 10.1002/sim.6835 (2016).
26. Burgess, S., Butterworth, A. & Thompson, S. G. Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data. Genetic epidemiology 37, 658-665, doi: 10.1002/gepi.21758 (2013).
27. Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator. Genetic epidemiology 40, 304-314, doi: 10.1002/gepi.21965 (2016).
28. Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44, 512-525, doi: 10.1093/ije/dyv080 (2015).
29. Palmer, T. M. et al. Using multiple genetic variants as instrumental variables for modifiable risk factors. Statistical methods in medical research 21, 223-242, doi: 10.1177/0962280210394459 (2012).
30. O'Seaghdha, C. M. et al. Meta-analysis of genome-wide association studies identifies six new Loci for serum calcium concentrations. PLoS genetics 9, e1003796, doi: 10.1371/journal.pgen.1003796 (2013).
31. Shin, C. S. & Kim, K. M. Calcium, Is It Better to Have Less? Global Health Perspectives. Journal of cellular biochemistry 116, 1513-1521, doi: 10.1002/jcb.25119 (2015).
32. Burgess, S. et al. Using published data in Mendelian randomization: a blueprint for efficient identification of causal risk factors. European journal of epidemiology 30, 543-552 (2015).
33. Hunter, D. J. et al. Genetic contribution to renal function and electrolyte balance: a twin study. Clin Sci (Lond) 103, 259-265, doi: 10.1042/ (2002).
34. Whitfield, J. B. & Martin, N. G. The effects of inheritance on constituents of plasma: a twin study on some biochemical variables. Annals of clinical biochemistry 21 (Pt 3), 176-183 (1984).
35. Greer, F. R., Tsang, R. C., Searcy, J. E., Levin, R. S. & Steichen, J. J. Mineral homeostasis during lactation-relationship to serum 1, 25-dihydroxyvitamin D, 25-hydroxyvitamin D, parathyroid hormone and calcitonin. The American journal of clinical nutrition 36, 431-437 (1982).
36. Brown, E. M. et al. Calcium-ion-sensing cell-surface receptors. The New England journal of medicine 333, 234-240, doi: 10.1056/ NEJM199507273330407 (1995).
37. Janicic, N. et al. Mapping of the calcium-sensing receptor gene (CASR) to human chromosome 3q13. 3-21 by fluorescence in situ hybridization, and localization to rat chromosome 11 and mouse chromosome 16. Mammalian Genome 6, 798-801 (1995).
38. Debacker, C., Catala, M. & Labastie, M. C. Embryonic expression of the human GATA-3 gene. Mech Dev 85, 183-187 (1999).
39. Shim, Y. S., Choi, W., Hwang, I. T. & Yang, S. Hypoparathyroidism, sensorineural deafness, and renal dysgenesis syndrome with a GATA3 mutation. Annals of pediatric endocrinology & metabolism 20, 59-63, doi: 10.6065/apem.2015.20.1.59 (2015).
40. Okawa, T. et al. A novel loss-of-function mutation of GATA3 (p.R299Q) in a Japanese family with Hypoparathyroidism, Deafness, and Renal Dysplasia (HDR) syndrome. BMC endocrine disorders 15, 66, doi: 10.1186/s12902-015-0065-7 (2015).
41. Zhu, Z. Y., Zhou, Q. L., Ni, S. N. & Gu, W. GATA3 mutation in a family with hypoparathyroidism, deafness and renal dysplasia syndrome. World journal of pediatrics: WJP 10, 278-280, doi: 10.1007/s12519-014-0505-x (2014).
42. Nanba, K. et al. A novel GATA3 nonsense mutation in a newly diagnosed adult patient of hypoparathyroidism, deafness, and renal dysplasia (HDR) syndrome. Endocrine practice: official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 19, e17-20, doi: 10.4158/ep12186.cr (2013).
43. Li, S. et al. Long-term calcium supplementation may have adverse effects on serum cholesterol and carotid intima-media thickness in postmenopausal women: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 98, 1353-1359, doi: 10.3945/ ajcn.113.062844 (2013).
44. Liu, L. et al. The effects of non-calcium-based phosphate binders versus calcium-based phosphate binders on cardiovascular calcification and bone remodeling among dialysis patients: a meta-analysis of randomized trials. Renal failure 36, 1244-1252 (2014).
45. Davie, E. W., Fujikawa, K. & Kisiel, W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 30, 10363-10370 (1991).
46. Hilgard, P. Experimental hypercalcaemia and whole blood clotting. J Clin Pathol 26, 616-619 (1973).
47. James, M. F. & Roche, A. M. Dose-response relationship between plasma ionized calcium concentration and thrombelastography. J Cardiothorac Vasc Anesth 18, 581-586 (2004).
48. Taylor, A. E. et al. Mendelian randomization in health research: using appropriate genetic variants and avoiding biased estimates. Economics and human biology 13, 99-106, doi: 10.1016/j.ehb.2013.12.002 (2014).
49. Burgess, S. & Thompson, S. G. Use of allele scores as instrumental variables for Mendelian randomization. Int J Epidemiol 42, 1134-1144, doi: 10.1093/ije/dyt093 (2013).
50. Burgess, S., Davies, N. M. & Thompson, S. G. Bias due to participant overlap in two-sample Mendelian randomization. Genetic epidemiology 40, 597-608, doi: 10.1002/gepi.21998 (2016).
51. Bowden, J. et al. Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic. Int J Epidemiol, doi: 10.1093/ije/dyw220 (2016).